Tracking a cancer Drug's Real-World impact
NCT ID NCT05640102
Summary
This study is observing patients with a rare blood cancer called Waldenström macroglobulinemia who are taking the drug zanubrutinib. The goal is to better understand how well the drug works and what side effects patients experience in real-world settings, especially among different racial and ethnic groups. Researchers are collecting data from about 111 patients who are already taking or planning to take this medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WALDENSTROM MACROGLOBULINEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
City of Hope National Medical Center
RECRUITINGDuarte, California, 91010-3012, United States
-
Clearview Cancer Institute
RECRUITINGHuntsville, Alabama, 35805-2606, United States
-
Comprehensive Cancer Centers of Nevada
RECRUITINGLas Vegas, Nevada, 89169-3321, United States
-
Eisenhower Medical Center, Lucy Curci Cancer Center
RECRUITINGRancho Mirage, California, 92270-3221, United States
-
Hattiesburg Hematology and Oncology Clinic
RECRUITINGHattiesburg, Mississippi, 39401-7233, United States
-
Los Angeles Cancer Network (Lacn)
RECRUITINGGlendale, California, 91204-3640, United States
-
Pan American Oncology Trials, Llc
RECRUITINGRio Piedras, 00935, Puerto Rico
-
South Alabama Medical Science Foundation Mitchell Cancer Institute
RECRUITINGMobile, Alabama, 36604-1405, United States
Conditions
Explore the condition pages connected to this study.